Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Clinuvel Pharmaceuticals buy dokem

Clinuvel Pharmaceuticals
Start price
€4.35
30.09.16 / 50%
Target price
€9.50
30.03.17
Performance (%)
15.31%
End price
€5.02
30.03.17
Summary
This prediction ended on 30.03.17 with a price of €5.02. The prediction had a final performance of 15.31%. dokem has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Clinuvel Pharmaceuticals 4.785% 4.785% -12.217% -49.303%
iShares Core DAX® 0.437% 5.897% 8.047% 65.579%
iShares Nasdaq 100 1.057% 0.920% 28.466% 90.185%
iShares Nikkei 225® 1.769% 1.228% 47.574% 84.991%
iShares S&P 500 0.368% 1.920% 23.200% 70.760%

Comments by dokem for this prediction

In the thread Clinuvel Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 15.31%
Target price 9.500
Change
Ends at 30.03.17

dokem stimmt der Buy-Einschätzung von ValueFox zu

dokem stimmt am 30.09.2016 der Buy-Einschätzung von ValueFox mit dem Kursziel 12,6€ zu.
Überschrift: Clinuvel: "strong buy" nach erfolgreichem Markteintritt

dokem 
0
Report Share
30.09.16
Prediction Buy
Perf. (%) 15.31%
Target price 9.500
Change
Ends at 30.03.17

(Laufzeit überschritten)

dokem 
0
Report Share
30.03.17